Glenmark’s Coup: Gilead’s Riva Now CEO Of Spin-Out Innovation Firm

 
• By Anju Ghangurde

Glenmark has snagged a top name in oncology from Gilead to lead its spin-out innovation business.

Leadership
GLENMARK'S INNOVATION SPINOUT DRAWS TOP-LEVEL TALENT FROM GILEAD

More from Business

More from Scrip